This study showed that 5% S. siliquosum supplementation in rats with diet-induced metabolic syndrome decreased body weight and decreased retroperitoneal fat and liver fat but had no effect on systolic blood pressure, liver enzyme activities, lipid profile or glucose and insulin metabolism. This evidence concerns the gene INS and metabolic syndrome.